Company news
Lifecore Biomedical, Inc. (NASDAQ:LFCR) news
Every Lifecore Biomedical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 2
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
November 4, 2024
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
October 4, 2024
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
October 4, 2024
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
September 19, 2024
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
September 12, 2024
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
September 10, 2024
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 6, 2024
Lifecore Biomedical Announces Chief Financial Officer Transition
August 29, 2024
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
August 26, 2024
Lifecore Biomedical Announces Cooperation Agreement with 22NW
July 1, 2024
Lifecore Biomedical Completes Incremental Liquidity Initiatives
May 16, 2024
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
April 1, 2024
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
March 26, 2024
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
March 20, 2024
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
February 16, 2024
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 5, 2024
Lifecore Biomedical Provides Business Update
December 13, 2023
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
November 20, 2023
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
August 31, 2023
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
August 22, 2023
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
June 1, 2023
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
May 22, 2023
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
April 6, 2023
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
March 16, 2023
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
March 16, 2023
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
February 7, 2023
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
January 9, 2023
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
November 25, 2022
Lifecore Biomedical Announces Completion of Corporate Name Change
November 14, 2022
Lifecore to Manufacture New Innovative Drug for Treatment of Postoperative Pain Following Customer’s FDA Approval
May 17, 2021
Landec Announces Dawn Kimball as New Senior Vice President, Chief People Officer
October 31, 2019